share_log

国浩律师(上海)事务所关于三生国健药业(上海)股份有限公司2024年限制性股票激励计划调整及首次授予事项的法律意见书

Legal Opinion of Guohao Law Firm (Shanghai) on the 2024 Restricted Stock Incentive Plan Adjustment and Initial Grant Matters of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

SZSI ·  Jul 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more